216 related articles for article (PubMed ID: 4995326)
1. [Determination of adequate drug combinations in the treatment of cavernous tuberculosis].
Seri I
Prax Pneumol; 1971 Apr; 25(4):211-9. PubMed ID: 4995326
[No Abstract] [Full Text] [Related]
2. [The rate of destruction of sensitive mycobacteria as a factor in the development of resistance in cavitating pulmonary tuberculosis].
Seri I
Prax Pneumol; 1974 May; 28(5):256-62. PubMed ID: 4210051
[No Abstract] [Full Text] [Related]
3. [Comparative bacteriological study of sputum and resected lung particles in patients with tuberculosis].
Fisher EF; Gaĭnutdinova NSh; Liadunkina MM; Mulik MI
Lab Delo; 1969; 5():298-300. PubMed ID: 4185264
[No Abstract] [Full Text] [Related]
4. [Effect of the inhalation of tuberculostatic aerosols on the dynamics of bacterial excretion in pulmonary tuberculosis patients].
Protsiuk RG
Probl Tuberk; 1983 May; (5):38-42. PubMed ID: 6408637
[No Abstract] [Full Text] [Related]
5. Rifampin in the treatment of drug-resistant mycobacterium tuberculosis infections.
Vall-Spinosa A; Lester W; Moulding T; Davidson PT; McClatchy JK
N Engl J Med; 1970 Sep; 283(12):616-21. PubMed ID: 4988918
[No Abstract] [Full Text] [Related]
6. Chemotherapy of chronic pulmonary tuberculosis with polyresistant bacteria with reference to ethambutol and capreomycin.
Radenbach KL
Scand J Respir Dis Suppl; 1968; 65():195-206. PubMed ID: 4978461
[No Abstract] [Full Text] [Related]
7. [Approaches to combined therapy of pulmonary tuberculosis in adolescents excreting drug-resistant Mycobacterium tuberculosis].
Firsova VA; Rusakova LI; Grigor'eva ZP; Ryzhova AP; Iatskova TV; Poluéktova FG
Probl Tuberk; 2001; (1):28-30. PubMed ID: 11337776
[TBL] [Abstract][Full Text] [Related]
8. [Studies on the origin and clinical significance of smear-positive and culture-negative tubercle bacilli].
Tsukamura M; Toyama H
Kekkaku; 1984 Aug; 59(8):451-9. PubMed ID: 6438383
[No Abstract] [Full Text] [Related]
9. [Drug resistance of tubercle bacilli isolated from sputum in previously untreated pulmonary tuberculosis. 3].
Nakai H; Maekawa N; Nakanishi M; Kawai M; Naito M
Bull Chest Dis Res Inst Kyoto Univ; 1971 Jan; 4(1):15-24. PubMed ID: 5005481
[No Abstract] [Full Text] [Related]
10. Time to positivity in liquid culture predicts colony forming unit counts of Mycobacterium tuberculosis in sputum specimens.
Diacon AH; van der Merwe L; Demers AM; von Groote-Bidlingmaier F; Venter A; Donald PR
Tuberculosis (Edinb); 2014 Mar; 94(2):148-51. PubMed ID: 24456754
[TBL] [Abstract][Full Text] [Related]
11. [Clinical significance of Mycobacterium tuberculosis polydrug resistance in chronic destructive forms of pulmonary tuberculosis].
Bialik IB; Klimenko MT
Probl Tuberk; 1980 Oct; (10):68-70. PubMed ID: 6776517
[No Abstract] [Full Text] [Related]
12. [Prognostic value of isolation of drug-resistant Mycobacterium tuberculosis].
Astionenko AA
Vrach Delo; 1978 Dec; (12):27-30. PubMed ID: 105475
[No Abstract] [Full Text] [Related]
13. [Importance of directed bronchial secretion aspiration for the bacteriological diagnosis of tuberculosis].
Ewert EG
Z Tuberk Erkr Thoraxorg; 1967; 126(3):162-8. PubMed ID: 4971151
[No Abstract] [Full Text] [Related]
14. [Analysis of failures of chemotherapy of pulmonary tuberculosis in adults].
Anastasatu C; Mihăilescu P; Gartner A; Bogdănescu V
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1979; 28(3):153-8. PubMed ID: 229540
[No Abstract] [Full Text] [Related]
15. [Studies on tubercle bacilli resistant to secondary drugs in the resected specimens and sputum of pulmonary tuberculosis patients].
Kameda K; Kudo S; Iwai K; Ushikubo K
Kekkaku; 1970 Sep; 45(9):283-7. PubMed ID: 4989932
[No Abstract] [Full Text] [Related]
16. [Evaluation of BK positivity and resistance of Mycobacterium tuberculosis 1983-1986 in areas of Bosnia and Herzegovina].
Vinik LK; Konjicija A; Sutić N; Psorn-Rajs A; Matić M; Arslanagić N
Plucne Bolesti; 1988; 40(1-2):32-5. PubMed ID: 3141940
[No Abstract] [Full Text] [Related]
17. Chemotherapy of chronic destructive tuberculosis of the lungs and some disputable drugs.
Schmelev NA
Scand J Respir Dis Suppl; 1968; 65():147-50. PubMed ID: 4978458
[No Abstract] [Full Text] [Related]
18. [New cases of pulmonary tuberculosis treatment within DOTS strategy].
Zhangireev AA; Ismailov ShSh; Berikova EM
Probl Tuberk; 2000; (3):23-5. PubMed ID: 10900979
[TBL] [Abstract][Full Text] [Related]
19. [Comparative characteristics of disseminated pulmonary tuberculosis in patients isolating Mycobacterium tuberculosis with a high and low viability].
Koretskaia NM; Iarygina IV
Probl Tuberk Bolezn Legk; 2007; (2):17-20. PubMed ID: 17419328
[TBL] [Abstract][Full Text] [Related]
20. Drug resistance among acid-fast bacilli.
Kato-Maeda M; Sifuentes-Osornio J; Bobadilla-del-Valle M; Ruiz-Palacios GM; Ponce-de-León A
Lancet; 1999 May; 353(9165):1709. PubMed ID: 10335816
[No Abstract] [Full Text] [Related]
[Next] [New Search]
